Trials / Completed
CompletedNCT02879539
Cochlear Implant Low Power Strategy
Clinical Assessment of a Low Power Strategy for Cochlear Implant Recipients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- The Hearing Cooperative Research Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power savings are required. The aim of this study is to evaluate three experimental sets of MP3000 parameter sets, compared against the default ACE program. In the background for each of the four strategies, experimental noise reduction programs (SpatialNR and NR3) will also be in use. In an additional phase of the study, low stimulation rate ACE programs will also be evaluated against the default stimulation rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MP3000 sound coding strategy or ACE strategy with lower stimulation |
Timeline
- Start date
- 2015-03-31
- Primary completion
- 2017-01-27
- Completion
- 2017-01-27
- First posted
- 2016-08-25
- Last updated
- 2021-07-06
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT02879539. Inclusion in this directory is not an endorsement.